Screening adults for hypothyroidism could give 100,000 'a new lease of life'

Jan 24, 2011

A paper published in the latest issue of the Journal of Medical Screening concludes that screening women over the age of 50 and men over 65 for hypothyroidism could significantly improve the quality of life of 100,000 people in the UK.

Researchers from the Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, have shown that adults for (underactive thyroid) is worthwhile and would improve people’s .

Hypothyroidism arises from an underactive thyroid. The disease is often overlooked because the typical symptoms – lethargy, tiredness, weight gain, forgetfulness – are non-specific and often considered a natural consequence of ageing. Blood levels of thyroid stimulating hormone (TSH) are raised when the thyroid is underactive so research was undertaken to establish whether this could be a useful screening test for undiagnosed hypothyroidism.

The results indicate that population screening for hypothyroidism would be worthwhile. Approximately 1% of people screened would have a better quality of life, representing over 100,000 people in Britain. Professor Sir Nicholas Wald, Director of the Wolfson Institute and one of the authors of the paper says: “It is rare to be able to find chronic diseases in adults that can be identified by screening, but this research shows that screening adults for hypothyroidism would be worthwhile. The UK National Screening Committee can now consider pilot screening programmes.”

He added “We need to focus preventive medicine more on improving quality of life whenever this is achievable at a reasonable cost. Hypothyroidism screening may not save lives, but for those affected it could provide a new lease of life.”

The research used a simple and powerful design, a randomized double blind cross-over trial. The TSH measurement was performed on people attending for a general health assessment (women aged 50-79 and men aged 65-79) at BUPA Wellness Centres. Over 4000 people's TSH measurements were taken and 8% of people had values high enough to justify an invitation into the trial. Of these, 110 met the inclusion criteria, 56 of whom completed the cross-over trial taking thyroxine (thyroid hormone) and a placebo in random order each for four months. The participants were asked whether they felt better on one treatment or the other, without knowing which was which. Among the 16 who had a raised TSH level a few weeks apart, the results were striking: 11 were better on thyroxine and none better on placebo, a statistically highly significant result (four felt no different). The main symptoms relieved were tiredness and loss of memory. There was no indication of harm.

An editorial in the same issue of the Journal by Dr James Haddow of the Savjani Institute for Health Research in Maine, USA, states that “This study provides evidence that even mild deficiency is associated with symptomatology and that treatment leads to improved wellbeing”.

Explore further: No increased risk of second cancers with radiotx in pelvic CA

add to favorites email to friend print save as pdf

Related Stories

A new zest for life

May 29, 2007

[B]How the treatment of common thyroid disease reduces tiredness and the risk factors for heart disease[/B] Putting on weight and feeling lethargic? Then new research from Newcastle University and funded by Gateshead NHS ...

Thyroid treatment no 'quick fix' for weight loss in children

Jan 03, 2008

Children treated for hypothyroidism aren't likely to drop pounds with treatment for the condition says a new study in the Journal of Pediatrics. The study is the first to examine the link between hypothyroidism treatment ...

Hip fractures and thyroid disease linked in study

Nov 30, 2010

New research from UC Davis Health System finds that older men with subclinical thyroid dysfunction have an increased risk of suffering hip fractures and suggests that screening and treatment for thyroid dysfunction in its ...

Low thyroid function common in chronic kidney disease

Jun 11, 2008

Many patients with chronic kidney disease (CKD) have mild reductions in thyroid function, or subclinical hypothyroidism—a condition that becomes more common as kidney function declines, according to a study in the September ...

Recommended for you

Scientists zero in on how lung cancer spreads

Dec 24, 2014

Cancer Research UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells - meaning they can break loose and spread, according to ...

Scientists identify rare cancer's genetic pathways

Dec 24, 2014

An international research team, including four Simon Fraser University scientists, has identified the "mutational landscape" of intrahepatic cholangiocarcinoma (ICC), a rare, highly fatal form of liver cancer that disproportionately ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.